Galena Biopharma Inc news

   Watch this stock
Showing stories 1 - 10 of about 91   

Articles published

GALE 1.66 +0.02 (1.22%)
price chart
Why Galena Biopharma, Inc. Stock Crashed By 52% in 2014
The overall market may be on pace to deliver solid gains for investors in 2014, but shareholders in Galena Biopharma (NASDAQ: GALE ) can do nothing but shake their head in disappointment with their stock down 52% for the year.
Related articles »  
Why Galena Biopharma Inc. Stock Sank 13% in November
What: Shares of Galena Biopharma (NASDAQ: GALE ) , a biopharmaceutical company focused on developing immunotherapies to treat cancer, sank 13% in November, based on data from S&P Capital IQ, following a weak earnings report and a questionable ...
Related articles »  
Could Galena Biopharma, Inc. Be Running Out of Money?
Today, we're going to take a closer look at small-cap biopharmaceutical company Galena Biopharma (NASDAQ: GALE ) to get a better bead on what its current cash situation looks like, to determine whether or not it could be running out of money, and to ...
Why Galena Biopharma Inc. Stock Tumbled
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Galena Biopharma's (GALE) CEO Mark Ahn on Q2 2014 Results - Earnings ...  Seeking Alpha (registration)
Related articles »  
Brokerage Firm Price Target on Galena Biopharma Inc
MLV & Co. reiterates its view on Galena Biopharma Inc (NASDAQ:GALE) according to the research report released by the firm to its investors.
Wednesday Stock Updates: Volcano Corp , Galena Biopharma Inc , HDFC Bank ...  Rock Hill Daily
Why Galena Biopharma Inc. Shares Spiked Higher
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal  TheStreet.com
Related articles »  
Technical Scrutiny on Biotech Stocks - Galena Biopharma, Synta Pharma ...
Investor-Edge has initiated coverage on the following equities: Galena Biopharma Inc. (NASDAQ: GALE), Synta Pharmaceuticals Corporation (NASDAQ: SNTA), Merrimack Pharmaceuticals Inc. (NASDAQ: MACK), Vertex Pharmaceuticals Inc. (NASDAQ: ...
Galena Biopharma Inc Price Target Update
Galena Biopharma Inc (NASDAQ:GALE): 6 Brokerage firm Analysts have agreed with the mean estimate for the short term price target of $6.5 in Galena Biopharma Inc (NASDAQ:GALE). However, the stock price could fluctuate by $ 3.02 from the estimate as it ...
Maxim Group Reiterates $7.00 Price Target for Galena Biopharma (GALE)  The Legacy
Bullish and Outperform S&P 500: Galena Biopharma Inc , Qiagen NV  Ashburn Daily
Form 8-K Galena Biopharma, Inc. For: Jan 14
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.
Galena Biopharma to Present at the Noble Financial Capital Markets 11th ...
Galena Biopharma, Inc. GALE, +1.22% a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major medical needs across the full spectrum of cancer care, today announced that Mark W.
Company Watch: Galena Biopharma Inc (NASDAQ:GALE), LivePerson, Inc ...  Realist Investor